Literature DB >> 16256193

Regulation of transplacental water transfer: the role of fetoplacental venous tone.

P Brownbill1, C P Sibley.   

Abstract

We used the in vitro dually perfused human placental lobule to test the hypothesis that known vasoconstrictors of the fetal placental circulation, angiotensin II and the thromboxane mimetic U46619 could induce fetomaternal water transfer. Secondly, we used a combination of vasoconstrictor and mechanically induced increases in fetal placental circulatory pressure to examine the role of the venous system in this context. Fetal-side administration of angiotensin II (A-II) and U46619 (n=6 and n=9, for A-II and U46619, respectively) induced dose dependent, recoverable elevations in fetal inflow hydrostatic pressure (HP; A-II: maximum contractility=83 mmHg, EC50=22.0 nM; U46619: maximum contractility was not achieved, but exceeded the A-II effect) and loss of perfusate from the fetal side (A-II: EC50=70.2 nM, maximum fetal-side solvent loss=1906 microl/min; U46619: maximum fetal-side solvent loss was not achieved, but exceeded the A-II effect). Fetal-side solvent loss, for both agonists, was correlated linearly with fetomaternal inflow HP (FMIHP) in a biphasic manner (between 0 and 30 mmHg the slopes (+/-S.E.) were 6.4+/-2.2 and 17.1+/-5.8 microl/(min mmHg) for A-II and U46619, respectively; between 30 and 70 mmHg the slopes (+/-S.E.) were 35.6+/-6.5 and 43.7+/-15.9 microl/(min mmHg) for A-II and U46619, respectively). Increasing fetal-side lumenal pressure (n=3) by raising the fetal outflow catheter caused a loss of perfusate from the fetal side which was reduced in the presence of U46619 (fetal solvent loss per unit increase in fetal-side inflow HP: slopes were 1.198+/-0.123 and 0.783+/-0.085 microl/(min mmHg mmHg), respectively). Notwithstanding the possibility of fetoplacental arterial constriction, we conclude that vasoconstrictive agonists in the fetoplacental circulation affect venous resistance, causing fetomaternal fluid loss. These observations could be relevant to the oligohydramnios associated with intrauterine growth restriction, a condition associated with increased resistance in the umbilical circulation.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16256193     DOI: 10.1016/j.placenta.2005.08.002

Source DB:  PubMed          Journal:  Placenta        ISSN: 0143-4004            Impact factor:   3.481


  4 in total

1.  Reduced cystathionine γ-lyase and increased miR-21 expression are associated with increased vascular resistance in growth-restricted pregnancies: hydrogen sulfide as a placental vasodilator.

Authors:  Tereza Cindrova-Davies; Emilio A Herrera; Youguo Niu; John Kingdom; Dino A Giussani; Graham J Burton
Journal:  Am J Pathol       Date:  2013-02-12       Impact factor: 4.307

2.  Dysregulated flow-mediated vasodilatation in the human placenta in fetal growth restriction.

Authors:  Sarah Jones; Helen Bischof; Ingrid Lang; Gernot Desoye; Sue L Greenwood; Edward D Johnstone; Mark Wareing; Colin P Sibley; Paul Brownbill
Journal:  J Physiol       Date:  2015-06-08       Impact factor: 5.182

3.  Image-Based Modeling of Blood Flow and Oxygen Transfer in Feto-Placental Capillaries.

Authors:  Philip Pearce; Paul Brownbill; Jiří Janáček; Marie Jirkovská; Lucie Kubínová; Igor L Chernyavsky; Oliver E Jensen
Journal:  PLoS One       Date:  2016-10-27       Impact factor: 3.240

4.  Pericytes on placental capillaries in terminal villi preferentially cover endothelial junctions in regions furthest away from the trophoblast.

Authors:  Shelley E Harris; Kate Sh Matthews; Eleni Palaiologou; Stanimir A Tashev; Emma M Lofthouse; Jennifer Pearson-Farr; Patricia Goggin; David S Chatelet; David A Johnston; Maaike Sa Jongen; Anton M Page; Jane K Cleal; Rohan M Lewis
Journal:  Placenta       Date:  2020-11-07       Impact factor: 3.481

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.